CA2151128A1 - Peptides de la region ns3 du virus de l'hepatite c, anticorps diriges contre eux et methodes de detection du vhc - Google Patents

Peptides de la region ns3 du virus de l'hepatite c, anticorps diriges contre eux et methodes de detection du vhc

Info

Publication number
CA2151128A1
CA2151128A1 CA002151128A CA2151128A CA2151128A1 CA 2151128 A1 CA2151128 A1 CA 2151128A1 CA 002151128 A CA002151128 A CA 002151128A CA 2151128 A CA2151128 A CA 2151128A CA 2151128 A1 CA2151128 A1 CA 2151128A1
Authority
CA
Canada
Prior art keywords
hcv
antibodies
peptide
hepatitis
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002151128A
Other languages
English (en)
Inventor
Winand Johannes Antonius Habets
Pieter Jacob Boender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2151128A1 publication Critical patent/CA2151128A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002151128A 1992-12-07 1993-12-06 Peptides de la region ns3 du virus de l'hepatite c, anticorps diriges contre eux et methodes de detection du vhc Abandoned CA2151128A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92203802 1992-12-07
EP92203802.1 1993-06-25

Publications (1)

Publication Number Publication Date
CA2151128A1 true CA2151128A1 (fr) 1994-06-23

Family

ID=8211111

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002151128A Abandoned CA2151128A1 (fr) 1992-12-07 1993-12-06 Peptides de la region ns3 du virus de l'hepatite c, anticorps diriges contre eux et methodes de detection du vhc

Country Status (8)

Country Link
EP (1) EP0672065A1 (fr)
JP (1) JPH08505131A (fr)
KR (1) KR950704353A (fr)
AU (1) AU6653394A (fr)
CA (1) CA2151128A1 (fr)
FI (1) FI952778L (fr)
WO (1) WO1994013699A1 (fr)
ZA (1) ZA939169B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
EP1195381A1 (fr) 2000-09-28 2002-04-10 Immusystems GmbH Epitopes du virus de l'hépatite C spécifiques à des lymphocytes T de type CD4+

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8807310A (pt) * 1987-11-18 1990-03-13 Chiron Corp Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado

Also Published As

Publication number Publication date
JPH08505131A (ja) 1996-06-04
ZA939169B (en) 1994-08-08
FI952778A0 (fi) 1995-06-06
WO1994013699A1 (fr) 1994-06-23
EP0672065A1 (fr) 1995-09-20
AU6653394A (en) 1994-07-04
FI952778A7 (fi) 1995-07-19
KR950704353A (ko) 1995-11-20
FI952778L (fi) 1995-07-19

Similar Documents

Publication Publication Date Title
RU2130969C1 (ru) Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
EP0698216B2 (fr) Procedes de determination du virus de l'hepatite c et reactifs utilises
KR970010925B1 (ko) Hcv 펩티드-항원 및 c형 간염 바이러스(hcv)의 검사 방법
US5229491A (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
AU2679492A (en) Hepatitis c assay
Ferroni et al. Identification of four epitopes in hepatitis C virus core protein
US5620843A (en) Non-A non-B sequences
Akatsuka et al. B‐cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies
EP0525910A1 (fr) Peptide non-A, non-B
EP0672065A1 (fr) Virus de l'hepatite c (hcv), peptides non structurels-3, anticorps associes et procedes de detection du hcv
US5670310A (en) Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
CA2151126A1 (fr) Peptides de la region c33 du vhc, anticorps diriges contre eux et methodes de detection du vhc
EP0536838A2 (fr) Peptides non-A, non-B
WO1993011158A2 (fr) Peptides non-a, non-b
WO1993013127A1 (fr) Peptides immunochimiquement reactifs avec des anticorps diriges contre le virus de l'hepatite non a, non b
CA2162250C (fr) Methodes de typage du virus de l'hepatite c et reactifs utiles a cette fin
EP0593291A2 (fr) Protéine nonstructurale du virus de l'hépatite C, et méthode diagnostique et nécessaire

Legal Events

Date Code Title Description
FZDE Discontinued